Vectus Biosystems
- Short interest
- <0.01%
- as of 10 Nov 2025
- Reported shorts
- 1.1K
- Shares on issue
- 53.333M
Vectus Biosystems (VBS) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Vectus Biosystems (ASX:VBS) Stock Under Pressure: What Investors Should Know - Kalkine
Vectus Biosystems (ASX:VBS) Stock Under Pressure: What Investors Should Know Kalkine
Vectus Biosystems (ASX:VBS): Down 40% in a Month — A Closer Look at Its Market Performance - Kalkine
Vectus Biosystems (ASX:VBS): Down 40% in a Month — A Closer Look at Its Market Performance Kalkine
How Is Vectus Biosystems (ASX:VBS) Stock Performing After Falling 14%? - Kalkine
How Is Vectus Biosystems (ASX:VBS) Stock Performing After Falling 14%? Kalkine
FDA Pre-IND Meeting Request Granted for VB0004
other announcement
2026 Notice of Annual General Meeting & Proxy Form
other announcement
2026 Corporate Governance Statement & Appendix 4G
other announcement
Date of 2026 Annual General Meeting
other announcement
Change of Director's Interest Notice - MS
director_dealing announcement
Application for quotation of securities - VBS
other announcement

Dr Boreham’s Crucible: Vectus Biosystems in good company on the orphan route
Vectus is the first anti-fibrotic company to be targeting not just slowing progression but actually reversing idiopathic pulmonary fibrosis. ... Read More The post Dr Boreham’s Crucible: Vectus Biosystems in good company on the orphan route appeared first on Stockhead.
Vectus Biosystems Issues 176,703 Shares After Executive and Contractor Option Exercises on July 29, 2026
On 29 July 2026, Vectus Biosystems Limited (ASX: VBS) issued 176,703 fully paid ordinary shares following option exercises under its Employee Incentive Plan, with CEO and CTO Dr Tara Speranza receiving the majority of these shares. Key Points Vectus Biosystems Limited (ASX: VBS) issued 176,703 fully paid ordinary shares on 29 July 2026 Dr Tara Speranza, CEO and CTO, acquired 163,500 shares through option exercise under the Employee Incentive Plan A Vectus contractor received 13,203 shares fol...
Quarterly Activities & Appendix 4C Cash Flow Reports
other announcement
Vectus Biosystems Ltd (ASX: VBS) Shares Rise as One-Year Gains Reach 372.97% - Kalkine
Vectus Biosystems Ltd (ASX: VBS) Shares Rise as One-Year Gains Reach 372.97% Kalkine
VBS Engages CHRS as Regulatory Agent for FDA Submissions
other announcement
What's Driving Vectus Biosystems' (ASX: VBS) Share Price? - Kalkine
What's Driving Vectus Biosystems' (ASX: VBS) Share Price? Kalkine
Why Is Vectus Biosystems (ASX:VBS) on Investors' Radar Despite Today's Pullback? - Kalkine
Why Is Vectus Biosystems (ASX:VBS) on Investors' Radar Despite Today's Pullback? Kalkine
Quarterly Activities & Appendix 4C Cash Flow Reports
other announcement
Quarterly Activities & Appendix 4C Cash Flow Reports
other announcement
Quarterly Activities & Appendix 4C Cash Flow Reports
other announcement
Notice of 2025 Annual General Meeting & Proxy Form
other announcement
2025 Corporate Governance Statement & Appendix 4G
other announcement